Related Experiment Video
Updated: Jun 13, 2026

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
Matrix metalloproteinase inhibition delays wound healing and blocks the latent transforming growth
Ursula Mirastschijski1, Reinhild Schnabel, Juliane Claes
1Department of Plastic, Hand and Reconstructive Surgery, Hannover Medical School, Hannover, Germany.
Abstract:
The ability to regulate wound contraction is critical for wound healing as well as for pathological contractures. Matrix metalloproteinases (MMPs) have been demonstrated to be obligatory for normal wound healing. This study examined the effect that the broad-spectrum MMP inhibitor BB-94 has when applied topically to full-thickness skin excisional wounds in rats and its ability to inhibit the promotion of myofibroblast formation and function by the latent transforming-growth factor-beta1 (TGF-beta1). BB-94 delayed wound contraction, as well as all other associated aspects of wound healing examined, including myofibroblast formation, stromal cell proliferation, blood vessel formation, and epithelial wound coverage. Interestingly, BB-94 dramatically increased the level of latent and active MMP-9. The increased levels of active MMP-9 may eventually overcome the ability of BB-94 to inhibit this MMP and may explain why wound contraction and other associated events of wound healing were only delayed and not completely inhibited. BB-94 was also found to inhibit the ability of latent TGF-beta1 to promote the formation and function of myofibroblasts. These results suggest that BB-94 could delay wound closure through a twofold mechanism; by blocking keratinocyte migration and thereby blocking the necessary keratinocyte-fibroblast interactions needed for myofibroblast formation and by inhibiting the activation of latent TGF-beta1.
Insights
The broad-spectrum matrix metalloproteinase (MMP) inhibitor BB-94 delays wound healing by inhibiting myofibroblast formation and transforming growth factor-beta1 (TGF-beta1) activation. Increased MMP-9 levels may overcome BB-94
Area of Science:
- Wound Healing Research
- Dermatology
- Pharmacology
Background:
- Wound contraction regulation is vital for healing and pathological contractures.
- Matrix metalloproteinases (MMPs) are essential for normal wound healing processes.
- Transforming growth factor-beta1 (TGF-beta1) plays a role in myofibroblast formation and function.
Purpose of the Study:
- To investigate the topical effects of the MMP inhibitor BB-94 on wound healing in rats.
- To assess BB-94's impact on myofibroblast development and TGF-beta1 promotion.
- To elucidate the mechanisms underlying BB-94's influence on wound contraction.
Main Methods:
- Application of broad-spectrum MMP inhibitor BB-94 to full-thickness skin excisional wounds in rats.
- Evaluation of wound contraction, myofibroblast formation, cell proliferation, angiogenesis, and epithelialization.
- Measurement of latent and active MMP-9 levels and TGF-beta1 activation.
Main Results:
- BB-94 significantly delayed wound contraction and associated healing parameters.
- BB-94 inhibited myofibroblast formation, stromal cell proliferation, blood vessel formation, and epithelial coverage.
- BB-94 treatment led to a dramatic increase in both latent and active MMP-9 levels.
- BB-94 inhibited the promotion of myofibroblast formation and function by latent TGF-beta1.
Conclusions:
- BB-94 delays wound closure via a dual mechanism: inhibiting keratinocyte migration and subsequent myofibroblast formation, and blocking latent TGF-beta1 activation.
- Elevated MMP-9 levels may counteract BB-94's inhibitory effects, leading to delayed rather than complete inhibition of wound healing.
- These findings highlight the complex role of MMPs and TGF-beta1 in wound healing and the potential of MMP inhibitors in modulating these processes.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Phases of Wound Repair
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
TGF - β Signaling Pathway
Healing I: Introduction
